Luptakova Katarina 4
4 · Xilio Therapeutics, Inc. · Filed May 3, 2024
Insider Transaction Report
Form 4
Luptakova Katarina
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2024-05-01+59,333→ 59,333 totalExercise: $1.08Exp: 2034-04-30→ Common Stock (59,333 underlying)
Footnotes (1)
- [F1]The option award was granted on May 1, 2024 and shall vest on June 1, 2024 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until May 1, 2028.